By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an ...

The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker ...

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.

Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...

A bill package proposes requiring vaccines to be covered by private insurance and Medicaid in Pennsylvania. The bills, ...

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.